Lipoprotein(a) screening has moved into the spotlight. In March 2026, a major United States guideline began recommending that every adult have their lipoprotein(a) measured at least once. This is a clear shift from the older approach, which reserved the test for people at obvious risk. Lipoprotein(a), or Lp(a), is a largely inherited particle that raises the risk of heart attack, stroke, and aortic valve narrowing, independently of your usual cholesterol. In this article you will learn what changed in 2026, what the test measures, how to read your result, what to do about a high level, and what recent research suggests.
What changed in 2026?
On March 13, 2026, the new 2026 ACC/AHA/Multisociety Dyslipidemia Guideline was released, replacing the 2018 cholesterol guideline. For the first time in a US guideline, it recommends universal screening of adults for elevated lipoprotein(a), with special considerations for testing in children. It also restores low-density lipoprotein (LDL) treatment goals based on risk and promotes lifelong lipid testing.
This matters because earlier guidance treated the test as optional. National patient resources still describe lipoprotein(a) as a test usually ordered only for people at high risk, rather than a routine screen. The 2026 update reframes a single Lp(a) measurement as useful information for nearly everyone, since the result rarely changes over a lifetime and can reveal hidden risk that a standard cholesterol panel misses.
What lipoprotein(a) screening measures
Lipoprotein(a) is an LDL-like particle with an extra protein, apolipoprotein(a), attached. That structure makes it both prone to building plaque in arteries and to encouraging blood clots. Your level is set mostly by genetics, so it stays fairly stable from childhood onward. For a deeper explainer, our guide covers the lipoprotein(a) cardiovascular risk marker.
The screen itself is a simple blood draw, often added to a wider lipid workup. Our explainer walks through the standard lipid panel, which measures total cholesterol, LDL, HDL, and triglycerides. Lp(a) is not part of that basic panel, which is exactly why a dedicated request matters. Unlike a routine cholesterol test, lipoprotein(a) screening usually does not require fasting.
How to read your lipoprotein(a) result
Lp(a) is reported in one of two units: milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L). These units do not convert with a simple factor, so always check which one your laboratory used. The table below shows the reference points most commonly cited.
| Lipoprotein(a) level | In mg/dL | In nmol/L | Usual interpretation |
|---|---|---|---|
| Deseable | Below 30 | Below 75 | Low Lp(a)-related risk |
| Límite | 30 to 50 | 75 to 125 | Optimize other risk factors |
| Alto | Above 50 | Above 125 | Raised cardiovascular risk |
A single number is never the whole story. A clinician reads your result alongside age, sex, blood pressure, smoking status, diabetes, and the rest of your lipids. About one in five people carries a high level, often without knowing it, because atherosclerosis builds silently for years.
What a high result means and what to do
A high lipoprotein(a) does not cause symptoms on its own, and no medicine is yet approved to lower it specifically. So the practical goal is to reduce every other risk factor you can change. That means controlling LDL cholesterol, blood pressure, blood sugar, and weight, and stopping smoking, which sharply amplifies the danger of a high Lp(a).
Diet and exercise barely move the Lp(a) number itself, but they lower your overall cardiovascular risk, which is what counts. Some people benefit from a closer look at particle burden: our article explains the ApoB blood test, and our overview covers the advanced lipid panel. To act on the modifiable side, our guide breaks down healthy LDL cholesterol levels and our resource explains high cholesterol prevention.
Who benefits most from lipoprotein(a) screening
The 2026 guideline points toward testing every adult once, but some groups gain the most from an early result. The table contrasts the older, selective approach with the new, universal one.
| Approach | Who was tested | Limitation |
|---|---|---|
| Selective (pre-2026) | Family history of early heart disease, very high LDL, or prior events | Missed many people with silent, inherited risk |
| Universal (2026) | All adults, at least once; special rules for children | Requires wider awareness and access |
Testing is especially valuable if a close relative had a heart attack or stroke young, if you have familial hypercholesterolemia, or if you keep having cardiovascular events despite well-controlled LDL. Because Lp(a) is inherited, a high result in one person is a signal to discuss testing for first-degree relatives.
Cuándo buscar atención médica
A high Lp(a) is a long-term risk marker, not an emergency. Still, some symptoms always need urgent care: chest pain, sudden shortness of breath, or stroke warning signs such as face drooping, arm weakness, or trouble speaking. In those situations, call emergency services immediately rather than waiting for any blood test.
Últimos avances científicos
According to recent literature indexed in PubMed, the case for measuring Lp(a) has grown stronger, though a recent finding is not the same as settled practice. A 2024 review in The Lancet concluded that about one in five people carries high lipoprotein(a) and that at-risk individuals should have it measured once in their lifetime (DOI).
A large 30-year analysis of initially healthy women, published in the New England Journal of Medicine in 2024, found that a single combined measurement of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) predicted cardiovascular events decades later, supporting earlier risk assessment (DOI). Building on the same cohort, a 2026 study in JAMA Cardiology examined clinical thresholds and concluded that screening for elevated Lp(a) in the general population may be warranted (DOI). These are observational and cohort findings; they describe risk, not a treatment that lowers it.
Glosario
| Término | Definición |
|---|---|
| Lipoprotein(a) / Lp(a) | An LDL-like blood particle, largely inherited, that raises cardiovascular risk. |
| Apolipoprotein(a) | The extra protein attached to Lp(a) that drives its clot-promoting effect. |
| aterosclerosis | The gradual buildup of fatty plaque that narrows and stiffens arteries. |
| Estenosis de la válvula aórtica | Narrowing of the heart’s aortic valve, which Lp(a) can promote over time. |
| ASCVD | Atherosclerotic cardiovascular disease, including heart attack and stroke. |
| nmol/L vs mg/dL | Two lab units for Lp(a) that do not convert with a simple factor. |
| PCR-as | High-sensitivity C-reactive protein, a marker of low-grade inflammation. |
| Primary prevention | Action taken before a first heart attack or stroke to lower risk. |
Preguntas frecuentes
Is lipoprotein(a) screening a routine test now?
The 2026 US guideline recommends measuring Lp(a) at least once in all adults, which moves it toward routine use. In practice, availability and local coverage still vary, so ask your clinician whether and when the test makes sense for you. Because the result is stable for life, a single measurement is usually enough.
¿Necesito ayunar antes del examen?
Usually no. Lipoprotein(a) levels are stable and not strongly affected by a recent meal, so the sample can often be taken without fasting. If Lp(a) is drawn together with a full lipid panel, your provider may still give specific instructions, so follow the guidance you receive from the lab.
How often should lipoprotein(a) be measured?
For most people, once is enough, because the level is genetically set and changes little over a lifetime. A repeat test is sometimes considered after menopause or if the first result sat near a decision threshold. Your clinician decides based on your overall risk picture.
Can I lower a high lipoprotein(a)?
Currently no approved medicine targets Lp(a) directly, and lifestyle changes have little effect on the number itself. The proven strategy is to lower every other risk factor: LDL cholesterol, blood pressure, blood sugar, weight, and smoking. Several Lp(a)-lowering drugs are in late-stage trials but are not yet available in routine care.
Does a high result mean I will have a heart attack?
No. A high Lp(a) raises risk over time, but it is one factor among many, and many people with high levels never have an event. The point of screening is to identify hidden risk early so you and your clinician can act on what is changeable.
Fuentes
- Lipoprotein (a) Blood Test — MedlinePlus (US National Library of Medicine)
- Lipoprotein (a): Levels and Testing — Cleveland Clinic
- 2026 ACC/AHA/Multisociety Dyslipidemia Guideline Released — National Lipid Association
Lecturas adicionales
- Lipoprotein(a): understanding this cardiovascular risk marker
- Análisis del perfil lipídico: colesterol, LDL, HDL y triglicéridos.
- ApoB blood test: a clearer picture of heart risk
- Normal LDL levels: a guide to healthy ranges
- Perfil lipídico avanzado: ApoB, Lp(a) y análisis más exhaustivo del riesgo cardíaco.
Comprenda los resultados de su laboratorio con AI DiagMe.
Lipoprotein(a) rarely makes sense in isolation. It reads best next to your full lipid panel, your LDL and HDL cholesterol, your triglycerides, and sometimes ApoB or high-sensitivity CRP. Faced with those numbers and units, it is not always obvious where you stand. AI DiagMe helps you understand your lab results in clear language, so you can prepare a better conversation with your doctor. It does not diagnose and does not replace your physician; it simply makes your results easier to read.
Obtén la interpretación de tus resultados en minutos.
